- Home
- BRTX vs CSCI Comparison
BRTX vs CSCI Comparison
Compare BRTX & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- CSCI
- Stock Information
- Founded
- BRTX 1997
- CSCI 1990
- Country
- BRTX United States
- CSCI Canada
- Employees
- BRTX N/A
- CSCI N/A
- Industry
- BRTX Managed Health Care
- CSCI
- Sector
- BRTX Health Care
- CSCI
- Exchange
- BRTX Nasdaq
- CSCI NYSE
- Market Cap
- BRTX 11.3M
- CSCI 11.1M
- IPO Year
- BRTX N/A
- CSCI 1996
- Fundamental
- Price
- BRTX $1.41
- CSCI $2.66
- Analyst Decision
- BRTX Strong Buy
- CSCI
- Analyst Count
- BRTX 1
- CSCI 0
- Target Price
- BRTX $18.00
- CSCI N/A
- AVG Volume (30 Days)
- BRTX 100.5K
- CSCI 4.7K
- Earning Date
- BRTX 11-12-2024
- CSCI 11-12-2024
- Dividend Yield
- BRTX N/A
- CSCI N/A
- EPS Growth
- BRTX N/A
- CSCI N/A
- EPS
- BRTX N/A
- CSCI N/A
- Revenue
- BRTX $377,000.00
- CSCI $4,834,000.00
- Revenue This Year
- BRTX $482.76
- CSCI N/A
- Revenue Next Year
- BRTX $212.24
- CSCI N/A
- P/E Ratio
- BRTX N/A
- CSCI N/A
- Revenue Growth
- BRTX 189.55
- CSCI N/A
- 52 Week Low
- BRTX $1.03
- CSCI $2.62
- 52 Week High
- BRTX $3.67
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- BRTX 41.13
- CSCI N/A
- Support Level
- BRTX $1.40
- CSCI N/A
- Resistance Level
- BRTX $1.60
- CSCI N/A
- Average True Range (ATR)
- BRTX 0.10
- CSCI 0.00
- MACD
- BRTX 0.00
- CSCI 0.00
- Stochastic Oscillator
- BRTX 42.86
- CSCI 0.00
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.